The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

MONDAY, April 14, 2025 (HealthDay News) -- Current newborn screening for cystic fibrosis favors white children over those ...

While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...

A new 96-week study confirms the long-term safety and sustained efficacy of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6–11 years.